Artículos de revistas sobre el tema "Facteur VIII (FVIII)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Facteur VIII (FVIII)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Labrouche, S., C. Vergnes, J. Constans, A. Berard y G. Freyburger. "Augmentation du facteur VIII (FVIII) : recherche d’une implication moléculaire du LRP". Journal des Maladies Vasculaires 30, n.º 4 (septiembre de 2005): 6. http://dx.doi.org/10.1016/s0398-0499(05)86244-4.
Texto completoYada, Koji, Kenichi Ogiwara, Masaru Shibata, Midori Shima y Keiji Nogami. "Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII". Thrombosis and Haemostasis 105, n.º 06 (2011): 989–98. http://dx.doi.org/10.1160/th10-12-0781.
Texto completoYada, Koji, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama y Midori Shim. "Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII." Blood 114, n.º 22 (20 de noviembre de 2009): 3169. http://dx.doi.org/10.1182/blood.v114.22.3169.3169.
Texto completoNakajima, Yuto, Koji Yada, Keiji Nogami y Midori Shima. "A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation". Blood 132, Supplement 1 (29 de noviembre de 2018): 1162. http://dx.doi.org/10.1182/blood-2018-99-115645.
Texto completoOgiwara, Kenichi, Keiji Nogami, Masahiro Okuda, Katsumi Nishiya, Masahiro Takeyama y Midori Shima. "Interactions of Factor VIII with Tissue Factor Contributes to the Acceleration of Factor Xa Generation in the Initiation Phase of Blood Coagulation." Blood 114, n.º 22 (20 de noviembre de 2009): 3177. http://dx.doi.org/10.1182/blood.v114.22.3177.3177.
Texto completoOgiwara, Kenichi, Keiji Nogami, Tetsuhiro Soeda, Tomoko Matsumoto, Katsumi Nishiya y Midori Shima. "Mechanisms of Factor VIII Activation by Recombinant Factor VIIa Analog through Tissue Factor-Independent Manner". Blood 112, n.º 11 (16 de noviembre de 2008): 1028. http://dx.doi.org/10.1182/blood.v112.11.1028.1028.
Texto completoSoeda, Tetsuhiro, Keiji Nogami, Tomoko Matsumoto, Kenichi Ogiwara, Katsumi Nishiya y Midori Shima. "Tissue Factor-Dependent Activation of Factor VIII by Factor VIIa in the Early Phase of Blood Coagulation". Blood 112, n.º 11 (16 de noviembre de 2008): 1036. http://dx.doi.org/10.1182/blood.v112.11.1036.1036.
Texto completoShoko, Furukawa, Keiji Nogami, Kenichi Ogiwara y Midori Shima. "Mechanism of Tissue Factor (TF) Enhancing Factor (F)VIII Activity on FXa Generation in Initial Phase of Coagulation and Interaction Between TF and FVIII C2 Domain". Blood 128, n.º 22 (2 de diciembre de 2016): 1391. http://dx.doi.org/10.1182/blood.v128.22.1391.1391.
Texto completoRadtke, Klaus-Peter, Dean Chamberlain, John H. Griffin y Andrew J. Gale. "Whole Blood Thromboelastogram Assays Demonstrate Prolonged Factor VIIIa Potency for Recombinant Disulfide Bond-Stabilized Factor VIII Variants." Blood 104, n.º 11 (16 de noviembre de 2004): 2976. http://dx.doi.org/10.1182/blood.v104.11.2976.2976.
Texto completoMeeks, Shannon, Ernest T. Parker, Amy L. Dunn, John F. Healey y Pete Lollar. "Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model." Blood 114, n.º 22 (20 de noviembre de 2009): 27. http://dx.doi.org/10.1182/blood.v114.22.27.27.
Texto completoYada, Koji, Keiji Nogami, Kenichi Ogiwara y Midori Shima. "A novel mechanism of Enhancing the Haemostatic Effect in the Combination with Recombinant Factor VIII and Activated Prothrombin Complex Concentrate(APCC) in Hemophilia A Patients with Inhibitor". Blood 118, n.º 21 (18 de noviembre de 2011): 1178. http://dx.doi.org/10.1182/blood.v118.21.1178.1178.
Texto completoMesser, Amanda S., Barbara Ulmasov, Yogesh Kumar, Kanagasabai Vadivel, Degang Zhong, Philip Fay y S. Paul Bajaj. "Epitope Mapping of a Monoclonal Antibody to Factor VIII That Inhibits Factor IXa:Factor VIIIa Interaction and Thrombin Activation of Factor VIII". Blood 118, n.º 21 (18 de noviembre de 2011): 1177. http://dx.doi.org/10.1182/blood.v118.21.1177.1177.
Texto completoZakas, Philip, Kristopher Knight, Ernest T. Parker, H. Trent Spencer, Eric Gaucher y Christopher B. Doering. "Bioengineering Coagulation Factor VIII through Ancestral Protein Reconstruction". Blood 126, n.º 23 (3 de diciembre de 2015): 123. http://dx.doi.org/10.1182/blood.v126.23.123.123.
Texto completoOkayama, Yusuke, Masato Bingo, Kazuki Sakatoku, Hiroshi Okamura, Satoru Nanno, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino y Hirohisa Nakamae. "The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A". Blood Coagulation & Fibrinolysis 34, n.º 6 (19 de julio de 2023): 419–22. http://dx.doi.org/10.1097/mbc.0000000000001243.
Texto completoOgiwara, Kenichi, Midori Shima y Keiji Nogami. "Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms". Thrombosis and Haemostasis 106, n.º 10 (2011): 665–74. http://dx.doi.org/10.1160/th11-04-0264.
Texto completoRao, LV y SI Rapaport. "Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa". Blood 75, n.º 5 (1 de marzo de 1990): 1069–73. http://dx.doi.org/10.1182/blood.v75.5.1069.1069.
Texto completoRao, LV y SI Rapaport. "Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa". Blood 75, n.º 5 (1 de marzo de 1990): 1069–73. http://dx.doi.org/10.1182/blood.v75.5.1069.bloodjournal7551069.
Texto completoMinami, Hiroaki, Keiji Nogami, Takehisa Kitazawa, Kunihiro Hattori y Midori Shima. "FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910". Blood 124, n.º 21 (6 de diciembre de 2014): 1481. http://dx.doi.org/10.1182/blood.v124.21.1481.1481.
Texto completoDoshi, Bhavya, Courtney Cox, Bagirath Gangadharan, Christopher B. Doering y Shannon L. Meeks. "Factor VIII Supplementation Improves Recombinant VIIa Initiated Thrombin Generation in Hemophilia A Inhibitor Patient Plasmas". Blood 118, n.º 21 (18 de noviembre de 2011): 28. http://dx.doi.org/10.1182/blood.v118.21.28.28.
Texto completoWilhelm, Amelia R., Nicole A. Parsons, Benjamin J. Samelson-Jones, Robert J. Davidson, Charles T. Esmon, Rodney M. Camire y Lindsey A. George. "Activated protein C has a regulatory role in factor VIII function". Blood 137, n.º 18 (6 de mayo de 2021): 2532–43. http://dx.doi.org/10.1182/blood.2020007562.
Texto completoGale, Andrew J., Diana Rozenshteyn y Justin Riceberg. "The Neutrophil Proteases, Elastase and Cathepsin G, May Modulate the Activity of Factor VIII." Blood 108, n.º 11 (16 de noviembre de 2006): 1716. http://dx.doi.org/10.1182/blood.v108.11.1716.1716.
Texto completoYada, Koji y Keiji Nogami. "Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab". Arteriosclerosis, Thrombosis, and Vascular Biology 40, n.º 5 (mayo de 2020): 1148–54. http://dx.doi.org/10.1161/atvbaha.120.312919.
Texto completoAddiego, Joseph E., Edward Gomperts, Liu Shu-Len, Patricia Bailey, Suzanne G. Courter, Martin L. Lee, Gerald G. Neslund, Henry S. Kingdon y Michael J. Griffith. "Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared by Anti-FVIIIc Immunoaffinity Chromatography". Thrombosis and Haemostasis 67, n.º 01 (1992): 019–27. http://dx.doi.org/10.1055/s-0038-1648373.
Texto completoNeuenschwander, Pierre F. "Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo." Blood 106, n.º 11 (16 de noviembre de 2005): 1020. http://dx.doi.org/10.1182/blood.v106.11.1020.1020.
Texto completoBloem, Esther, Henriet Meems, Maartje van den Biggelaar, Koen Mertens y Alexander B. Meijer. "Factor VIII Region 1811–1818 Is Involved in Factor IXa Binding and Factor VIIIa Stability". Blood 120, n.º 21 (16 de noviembre de 2012): 3357. http://dx.doi.org/10.1182/blood.v120.21.3357.3357.
Texto completoWilhelm, Amelia R., Nicole A. Parsons, Charles T. Esmon, Rodney M. Camire y Lindsey A. George. "In Vivo hemostatic Significance of Activated Protein C in Factor VIIIa Regulation". Blood 134, Supplement_1 (13 de noviembre de 2019): 93. http://dx.doi.org/10.1182/blood-2019-124493.
Texto completoHealey, John F., Ernest Parker y John (Pete) S. Lollar. "Comparative Decay Rates of Human, Rhesus Macaque, Cynomolgus, and Porcine Activated Factor VIII." Blood 114, n.º 22 (20 de noviembre de 2009): 3164. http://dx.doi.org/10.1182/blood.v114.22.3164.3164.
Texto completoRozenshteyn, Diana y Andrew J. Gale. "Cathepsin G, a leukocyte protease, activates coagulation factor VIII". Thrombosis and Haemostasis 99, n.º 01 (2008): 44–51. http://dx.doi.org/10.1160/th07-08-0495.
Texto completovan 't Veer, C., TM Hackeng, C. Delahaye, JJ Sixma y BN Bouma. "Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor". Blood 84, n.º 4 (15 de agosto de 1994): 1132–42. http://dx.doi.org/10.1182/blood.v84.4.1132.1132.
Texto completovan 't Veer, C., TM Hackeng, C. Delahaye, JJ Sixma y BN Bouma. "Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor". Blood 84, n.º 4 (15 de agosto de 1994): 1132–42. http://dx.doi.org/10.1182/blood.v84.4.1132.bloodjournal8441132.
Texto completoMazurier, Claudine, Armelle Parquet-Gernez y Maurice Goudemand. "Validation of a Procedure for Potency Assessing of a High Purity Factor VIII Concentrate -Comparison of Different Factor VIII Coagulant Assays and Effect of Prediluent". Thrombosis and Haemostasis 64, n.º 02 (1990): 251–55. http://dx.doi.org/10.1055/s-0038-1647295.
Texto completoTakeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori y Midori Shima. "Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity". Thrombosis and Haemostasis 103, n.º 01 (2010): 94–102. http://dx.doi.org/10.1160/th09-05-0338.
Texto completoPeerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A". Blood 93, n.º 7 (1 de abril de 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.
Texto completoPeerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A". Blood 93, n.º 7 (1 de abril de 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.407k21_2267_2273.
Texto completoPonder, Katherine P. "FIXing Factor VIII inhibitors". Blood 119, n.º 2 (12 de enero de 2012): 325–26. http://dx.doi.org/10.1182/blood-2011-11-389486.
Texto completoZhong, Degang, Evgueni L. Saenko, Midori Shima, Matthew Felch y Dorothea Scandella. "Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX". Blood 92, n.º 1 (1 de julio de 1998): 136–42. http://dx.doi.org/10.1182/blood.v92.1.136.413k35_136_142.
Texto completoHsu, Ting-Chang, Kathleen P. Pratt y Arthur R. Thompson. "The factor VIII C1 domain contributes to platelet binding". Blood 111, n.º 1 (1 de enero de 2008): 200–208. http://dx.doi.org/10.1182/blood-2007-01-068957.
Texto completoGrushin, Kirill, Jaimy Miller, Daniela Dalm y Svetla Stoilova-McPhie. "Factor VIII organisation on nanodiscs with different lipid composition". Thrombosis and Haemostasis 113, n.º 04 (julio de 2015): 741–49. http://dx.doi.org/10.1160/th14-09-0725.
Texto completoHakeos, William, Hongzhi Miao, Nongnuch Sirachainan, Geoffrey Kemball-Cook, Evgueni Saenko, Randal Kaufman y Steven Pipe. "Hemophilia A Mutations within the Factor VIII A2-A3 Subunit Interface Destabilize Factor VIIIa and Cause One-stage/ Two-stage Activity Discrepancy". Thrombosis and Haemostasis 88, n.º 11 (2002): 781–87. http://dx.doi.org/10.1055/s-0037-1613302.
Texto completoStrijbis, Viola J. F., Ka Lei Cheung, Pavlina Konstantinova, Ying Poi Liu, Sander J. van Deventer y Mettine H. A. Bos. "Evaluation of a Blood Coagulation Factor IX Variant That Functions Independently of Factor VIII As an Alternative Treatment for Hemophilia A". Blood 134, Supplement_1 (13 de noviembre de 2019): 1110. http://dx.doi.org/10.1182/blood-2019-124120.
Texto completoSen, Prosenjit, Curtis A. Clark, Ramakrishnan Gopalakrishnan, Ulla Hedner, Charles T. Esmon, Usha R. Pendurthi y L. Vijaya Rao. "Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems". Thrombosis and Haemostasis 107, n.º 05 (2012): 951–61. http://dx.doi.org/10.1160/th11-09-0672.
Texto completoLannert, Kerry W., Hilary S. Gammill, Barbara A. Konkle y Jill M. Johnsen. "The Ability of Von Willebrand Factor (VWF) to Bind Factor VIII (FVIII) Can Decrease during Pregnancy". Blood 124, n.º 21 (6 de diciembre de 2014): 4244. http://dx.doi.org/10.1182/blood.v124.21.4244.4244.
Texto completoRolli, Veronique, Nathalie Enjolras, Cecile Ducasse, Marie-Helene Rodriguez, Thomas Weimer, Hans-Peter Hauser, Claude Negrier y Jean-Luc Plantier. "Generation of Factor VIII Molecules Partially Resistant to Activated Protein C." Blood 104, n.º 11 (16 de noviembre de 2004): 1729. http://dx.doi.org/10.1182/blood.v104.11.1729.1729.
Texto completoMarkovitz, Rebecca C., John F. Healey, Ernest T. Parker, Shannon L. Meeks y Pete Lollar. "The diversity of the immune response to the A2 domain of human factor VIII". Blood 121, n.º 14 (4 de abril de 2013): 2785–95. http://dx.doi.org/10.1182/blood-2012-09-456582.
Texto completoGolino, Paolo, Massimo Ragni, Plinio Cirillo, Annalisa Scognamiglio, Amelia Ravera, Chiara Buono, Angela Guarino et al. "Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits". American Journal of Physiology-Heart and Circulatory Physiology 278, n.º 5 (1 de mayo de 2000): H1507—H1516. http://dx.doi.org/10.1152/ajpheart.2000.278.5.h1507.
Texto completoJenkins, P. Vincent, Jan Freas, Kyla M. Schmidt, Qian Zhou y Philip J. Fay. "Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex". Blood 100, n.º 2 (15 de julio de 2002): 501–8. http://dx.doi.org/10.1182/blood-2001-12-0361.
Texto completoWakabayashi, Hironao, Jennifer Wintermute y Philip J. Fay. "Stabilizing Factor VIIIa By Combining Mutations That Modulate Inter-Subunit Interactions and Proteolytic Inactivation". Blood 122, n.º 21 (15 de noviembre de 2013): 3572. http://dx.doi.org/10.1182/blood.v122.21.3572.3572.
Texto completoGangadharan, Bagirath, H. Trent Spencer, Ernest T. Parker y Christopher B. Doering. "High-Level Expression of Porcine Factor VIII from Murine Mesenchymal Stem Cells." Blood 104, n.º 11 (16 de noviembre de 2004): 5281. http://dx.doi.org/10.1182/blood.v104.11.5281.5281.
Texto completoCooper, Adrian, Zhong Liang, Francis Castellino y Elliot Rosen. "Cloning and Characterization of the Murine Coagulation Factor X Gene". Thrombosis and Haemostasis 83, n.º 05 (2000): 732–35. http://dx.doi.org/10.1055/s-0037-1613901.
Texto completoOgiwara, Kenichi, Tomoko Matsumoto, Katsumi Nishiya, Masahiro Takeyama, Midori Shima y Keiji Nogami. "Mechanisms of human neutrophil elastase-catalysed inactivation of factor VIII(a)". Thrombosis and Haemostasis 105, n.º 06 (2011): 968–80. http://dx.doi.org/10.1160/th10-12-0777.
Texto completo